Delivery Order SPE2DB22D3004-SPE2DB23FQV64
Award Date 7/28/23
Potential Completion Date 7/31/23
Potential Value $354
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,354 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562048946 units of 1 mg vials of remifentanil. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 6, 2023 in support of DLA programs. Remifentanil is an opioid analgesic for medical use as an anesthetic adjunct. This order was awarded under an existing DLA pharmaceutical supply vehicle and no set aside designation...
- The Defense Logistics Agency awarded a $4,596.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561422255 units of 1 mg vials of remifentanil. The one-day contract has a period of performance from July 6 to July 7, 2023, with all work to be conducted by the prime contractor at its facility located in Conshohocken, Pennsylvania. The DLA supports military treatment facilities and healthcare providers through its medical product procurement and distribution activities....
- <p>This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corporation $708 to supply 1 mg vials of remifentanil, an opioid analgesic, by October 19, 2023. The firm fixed price order was awarded on October 18, 2023 to the vendor's Conshohocken, Pennsylvania location under an existing contract vehicle. No set-aside provisions were applied to this order for remifentanil, which will support the Defense Logistics Agency's medical supply chain needs.</p>
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $3,668 delivery order contract to provide 1 mg vials of the opioid analgesic remifentanil. As the prime contractor, Amerisourcebergen will deliver the drug to its place of performance in Conshohocken, Pennsylvania under a firm fixed price arrangement. The single-day period of performance between August 15-16, 2023 suggests this is a small, short-term order under the Defense Logistics Agency's prime vendor pharmaceutical...
- The Defense Logistics Agency awarded a $9,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation to supply 2 mg vials of the opioid analgesic remifentanil. Performance will take place in Conshohocken, Pennsylvania over a one-day period concluding on August 30, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will serve as the prime contractor in fulfilling the Defense Logistics Agency's requirement for this controlled pharmaceutical under an unstated...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $3,612.50 to provide 4561740719 units of the drug remifentanil hydrochloride in 1 mg vials. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in August 2023. As a major distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen is well positioned to fulfill this small order for...
- The Defense Logistics Agency awarded a $3,182 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561356070 REMIFENTANIL 1 MG VIALS. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the requested pharmaceutical products to the location specified in Conshohocken, Pennsylvania by the scheduled completion date of June 28, 2023. The Defense Logistics Agency supports Department of Defense procurement and supply chain management programs through...
- The Defense Logistics Agency awarded a delivery order valued at $11,983.47 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, a potent opioid analgesic commonly used in clinical and surgical settings. This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance...
- The Defense Logistics Agency Troop Support Medical awarded a $1,768 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,056 vials of the analgesic remifentanil. The single order is for product delivery to a location in Conshohocken, Pennsylvania by July 26, 2023, under an indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the U.S....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Remifentanil 5 mg vials under a firm fixed-price contract valued at $19,618.24, with an ultimate completion date of October 23, 2025. This non-competitive, non-set-aside delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The award is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB23FQV64Delivery Order
The Defense Logistics Agency awarded a $353,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1 mg vials of the opioid analgesic remifentanil. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility by July 31, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were indicated. The order was placed under an existing DLA pharmaceuticals contract vehicle to fulfill demand for remifentanil, a short-acting opioid often used in surgical settings.
Generated 12/19/23, 7:35 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $354 | 7/28/23 |